Vimarsana
Biggest News Aggregation in the World

Page 18 - King Io News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from King Io. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In King Io Today - Breaking & Trending Today

Loneliness during teenage years increases risk of many negative outcomes - Vimarsana News

Loneliness during teenage years increases risk of many negative outcomes

New research from the Institute of Psychiatry, Psychology, & Neuroscience at King's College London has found that young people who experience loneliness during early adolescence (age 12) are at greater risk of leaving school with lower grades than their non-lonely counterparts, even if they stop being lonely later on.

Research suggests virtual reality 'shopping task' can help reduce cognitive decline in adults - Vimarsana News

Research suggests virtual reality 'shopping task' can help reduce cognitive decline in adults

Virtual reality games and tests are known to help children improve cognitive skills, but what about adults? New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, has made some interesting discoveries about the same.

Virtual reality 'Shopping Task' could help test for cognitive decline in adults - Vimarsana News

Virtual reality 'Shopping Task' could help test for cognitive decline in adults

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London suggests that a virtual reality test in

People from ethnic minority backgrounds experience persisting inequality - Vimarsana News

People from ethnic minority backgrounds experience persisting inequality

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has assessed the prevalence of common mental

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg - Vimarsana News

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg

New research from the Institute of Psychiatry, Psychology, & Neuroscience (IoPPN) at King's College London, in partnership with COMPASS Pathways, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants simultaneously.